EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Conceptualizing cognition and behaviour across amyotrophic lateral sclerosis and frontotemporal dementia

Michael Benatar iD, Edward D Huey, Chiadi U Onyike, Caroline McHutchison iD, Maria Carmela Tartaglia, Megan S Barker, Sharon Abrahams, Joke De Vocht, Emma Rhodes iD, Yolande A Pijnenburg, Martin R Turner iD, Philip van Damme iD und 6 weitere

Brain · 10.09.2026

DOI: 10.1093/brain/awag300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 10.09.2026. Verfasst von Michael Benatar und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and the ALS Center, Miller School of Medicine, University of Miami, Miami, FL, 33129, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ALS Society, Temerty Family Foundation, Biogen Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cognitive and behavioural dysfunction in frontotemporal dementia (FTD) evolves along a clinical continuum from a clinically silent stage of disease, through a prodromal period, often referred to as mild cognitive impairment (MCI) and/or mild behavioural impairment (MBI), and into a clinically manifest stage recognized by the syndromes of behavioural variant FTD and primary progressive aphasia (PPA). Similar cognitive and behavioural manifestations of varying severity are also encountered in individuals with amyotrophic lateral sclerosis (ALS). Notwithstanding this phenotypic overlap as well as a degree of shared genetic risk and underlying pathology, the approach to phenotypic characterization and description meaningfully differs between the ALS and FTD communities. The problem is particularly evident within the ALS community when describing impairment in the prodromal versus clinically manifest disease stages. Pertinent considerations include the nature of cognitive and behavioural assessments, the nosology used to describe symptoms identified, including those encompassed by the terms ‘behavioural’ and ‘neuropsychiatric’, the operationalized criteria that define prodromal syndromes and clinically manifest disease, and the extent to which these criteria rely on longitudinal (versus cross-sectional) data. A multi-stakeholder workshop, held in London, Ontario (12–14 May 2025), brought together neurologists, psychiatrists, neuropsychologists, neuropathologists, neuroscientists and neurogeneticists studying ALS and FTD, to promote interdisciplinary dialogue and to define a research agenda that might be jointly tackled to address these critical issues. A new nosology for classifying frontotemporal-related behavioural and neuropsychiatric dysfunction, which could be used to support empirical evidence collection, is proposed alongside a list of cognitive, language, behavioural and neuropsychiatric symptoms to be considered in the evaluation of individuals with ALS. Research priorities for each of the ALS and FTD communities, as well as initiatives that should be undertaken jointly, are highlighted. The long-term goal is to harmonize approaches to phenotypic characterization, the nosology used to describe symptoms and the criteria used to define landmark stages along the clinical continua of the motor neuron and frontotemporal axes, irrespective of clinical stage.

Schlagwörter

Stichwörter der Autor:innen

clinically manifest diseasemild behavioral impairmentmild cognitive impairmentpre-symptomatic diseaseprodromal disease

Autor:innen und Institutionen

  • Department of Neurology and the ALS Center, Miller School of Medicine, University of Miami, Miami, FL, 33129, USA.
  • Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, 02906, USA.
  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Division of Psychology, Faculty of Natural Sciences, University of Stirling, FK9 4LA, UK.
  • Euan MacDonald Centre for MND Research, University of Edinburgh, EH16 4SB, UK.
  • Division of Neurology University of Toronto, Toronto, ON, M5T 1A8, Canada.

ORCID-Profile: Michael Benatar, Caroline McHutchison, Emma Rhodes, Martin R Turner, Philip van Damme, Edward B Lee, Alberto Benussi, Bradley F Boeve

Förderung

  • ALS Society
  • Temerty Family Foundation
  • Biogen Canada
  • ALS Society of Canada
  • Alector
  • Eli Lilly and Company
  • Motor Neurone Disease Association
  • Mitsubishi Tanabe Pharma

Zitieren

APA

Benatar, M., Huey, E. D., Onyike, C. U., McHutchison, C., Tartaglia, M. C., Barker, M. S., Abrahams, S., De Vocht, J., Rhodes, E., Pijnenburg, Y. A., Turner, M. R., van Damme, P., Lee, E. B., Wuu, J., Benussi, A., Boeve, B. F., McMillan, C. T., & Strong, M. J. (2026). Conceptualizing cognition and behaviour across amyotrophic lateral sclerosis and frontotemporal dementia. Brain. https://doi.org/10.1093/brain/awag300

Vancouver

Benatar M, Huey ED, Onyike CU, McHutchison C, Tartaglia MC, Barker MS, et al. Conceptualizing cognition and behaviour across amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2026. doi:10.1093/brain/awag300

BibTeX
@article{Benatar2026,
  author = {Benatar, Michael and Huey, Edward D and Onyike, Chiadi U and McHutchison, Caroline and Tartaglia, Maria Carmela and Barker, Megan S and Abrahams, Sharon and De Vocht, Joke and Rhodes, Emma and Pijnenburg, Yolande A and Turner, Martin R and van Damme, Philip and Lee, Edward B and Wuu, Joanne and Benussi, Alberto and Boeve, Bradley F and McMillan, Corey T and Strong, Michael J},
  title = {Conceptualizing cognition and behaviour across amyotrophic lateral sclerosis and frontotemporal dementia},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awag300}
}
Kostenlos starten →